Shanghai Haohai Biological Technology Co., Ltd.

Informe acción SHSC:6826

Capitalización de mercado: HK$15.0b

Shanghai Haohai Biological Technology Crecimiento futuro

Future controles de criterios 3/6

Shanghai Haohai Biological Technology is forecast to grow earnings and revenue by 18.6% and 12.5% per annum respectively. EPS is expected to grow by 21.3% per annum. Return on equity is forecast to be 10.3% in 3 years.

Información clave

18.6%

Tasa de crecimiento de los beneficios

21.3%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Biotechs41.8%
Tasa de crecimiento de los ingresos12.5%
Rentabilidad financiera futura10.3%
Cobertura de analistas

Low

Última actualización26 Aug 2024

Actualizaciones recientes sobre el crecimiento futuro

No hay actualizaciones

Recent updates

Previsiones de crecimiento de beneficios e ingresos

SHSC:6826 - Estimaciones futuras de los analistas y datos financieros pasados (CNY Millions)
FechaIngresosBeneficiosFlujo de caja libreFlujo de caja operativoNúm. de analistas medio
12/31/20263,650684N/AN/A1
12/31/20253,315605N/AN/A1
12/31/20242,907515N/AN/A1
9/30/20242,747430325674N/A
6/30/20242,746446296679N/A
3/31/20242,689432239630N/A
12/31/20232,654416367634N/A
9/30/20232,53034699442N/A
6/30/20232,48731592401N/A
3/31/20232,263226-35254N/A
12/31/20222,130180-86231N/A
9/30/20222,06320352343N/A
6/30/20221,86119257336N/A
3/31/20221,80527264339N/A
12/31/20211,75035270342N/A
9/30/20211,702428115333N/A
6/30/20211,674434120342N/A
3/31/20211,594370N/AN/AN/A
12/31/20201,32423066262N/A
9/30/20201,343232-20258N/A
6/30/20201,3062166258N/A
3/31/20201,437279N/AN/AN/A
12/31/20191,595371-50349N/A
9/30/20191,537353-8286N/A
6/30/20191,570386-7302N/A
3/31/20191,478375N/AN/AN/A
12/31/20181,546415239391N/A
9/30/20181,523411235398N/A
6/30/20181,501408N/A404N/A
3/31/20181,423390N/A374N/A
12/31/20171,345372N/A343N/A
9/30/20171,214351N/A330N/A
6/30/20171,083329N/A317N/A
3/31/2017967317N/A286N/A
12/31/2016851305N/A254N/A
9/30/2016787295N/A245N/A
6/30/2016724284N/A235N/A
3/31/2016694279N/A252N/A
12/31/2015664273N/A269N/A
9/30/2015630258N/A244N/A
6/30/2015597243N/A219N/A
3/31/2015556213N/A181N/A
12/31/2014516184N/A142N/A
9/30/2014482169N/A135N/A
6/30/2014449154N/A128N/A
3/31/2014425148N/A137N/A
12/31/2013401142N/A147N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: 6826's forecast earnings growth (18.6% per year) is above the savings rate (2.3%).

Beneficios vs. Mercado: 6826's earnings (18.6% per year) are forecast to grow faster than the Hong Kong market (11.5% per year).

Beneficios de alto crecimiento: 6826's earnings are forecast to grow, but not significantly.

Ingresos vs. Mercado: 6826's revenue (12.5% per year) is forecast to grow faster than the Hong Kong market (7.7% per year).

Ingresos de alto crecimiento: 6826's revenue (12.5% per year) is forecast to grow slower than 20% per year.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: 6826's Return on Equity is forecast to be low in 3 years time (10.3%).

Descubre empresas en crecimiento

7D

1Y

7D

1Y

7D

1Y